Li Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Li Wang has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Guofeng Wang
Department of Endocrinology, The First People’s Hospital of Lianyungang
1 shared publication Lin Hu
Department of Endocrinology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China
1 shared publication- Ling Li
Department of Endocrinology, Zhongda Hospital, Southeast University, Nanjing 210009, China
1 shared publication Teng-Fang Lai
Department of Cardiology, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China
1 shared publicationXiang-Hui Su
Department of Endocrinology, Changji Branch, The First Affiliated Hospital of Xinjiang Medical University, Changji, China
1 shared publicationYing-Qi Lv
Department of Endocrinology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China
1 shared publication
Latest Publications
- Open Access
- 8 July 2025
- Published by Springer Nature in European Journal of Medical Research
- Vol. 30 (1) , 1-6
Association between serum carcinoembryonic antigen levels and atherosclerotic cardiovascular disease in patients with type 2 diabetes mellitus
Atherosclerotic cardiovascular disease (ASCVD) is cardiovascular disease caused by atherosclerosis. Serum carcinoembryonic antigen (CEA), a common tumor marker, is positively associated with arterial stiffness in healthy adults. Therefore, the aim of this study was to explore the potential association between serum CEA levels and ASCVD in patients with type 2 diabetes mellitus (T2DM). We retrospectively included 1392 patients with T2DM stratified into those with ASCVD and those without ASCVD, and the accumulated data were systematically analyzed between groups. A significant increase in serum CEA levels was observed in T2DM patients with ASCVD compared with those without ASCVD (2.70[1.93–3.98] vs. 2.35[1.60–3.54] ng/mL, p < 0.001). Serum CEA levels were significantly positively correlated with brachial-ankle pulse wave velocity in patients with T2DM (r = 0.151, p < 0.001). Multivariable logistic regression analysis revealed that increased serum CEA levels were independently associated with ASCVD in patients with T2DM (OR = 1.100, 95%CI 1.006–1.203, p = 0.037). Increased serum CEA levels were independently associated with ASCVD in patients with T2DM. The finding highlights that ASCVD may influence the interpretation of serum CEA levels during tumor screening in this population.
- 8 July 2025
- Published by Springer Nature in European Journal of Medical Research
- Vol. 30 (1) , 1-6
Open AccessAssociation between serum carcinoembryonic antigen levels and atherosclerotic cardiovascular disease in patients with type 2 diabetes mellitus
Atherosclerotic cardiovascular disease (ASCVD) is cardiovascular disease caused by atherosclerosis. Serum carcinoembryonic antigen (CEA), a common tumor marker, is positively associated with arterial stiffness in healthy adults. Therefore, the aim of this study was to explore the potential association between serum CEA levels and ASCVD in patients with type 2 diabetes mellitus (T2DM). We retrospectively included 1392 patients with T2DM stratified into those with ASCVD and those without ASCVD, and the accumulated data were systematically analyzed between groups. A significant increase in serum CEA levels was observed in T2DM patients with ASCVD compared with those without ASCVD (2.70[1.93–3.98] vs. 2.35[1.60–3.54] ng/mL, p < 0.001). Serum CEA levels were significantly positively correlated with brachial-ankle pulse wave velocity in patients with T2DM (r = 0.151, p < 0.001). Multivariable logistic regression analysis revealed that increased serum CEA levels were independently associated with ASCVD in patients with T2DM (OR = 1.100, 95%CI 1.006–1.203, p = 0.037). Increased serum CEA levels were independently associated with ASCVD in patients with T2DM. The finding highlights that ASCVD may influence the interpretation of serum CEA levels during tumor screening in this population.